Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
228.00    0.00 (0.00%)
Bid:
227.50
Ask:
228.50
Spread: 1.00 (0.44%)
Market Cap: £630.23m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

Interim Management Statement

17 Nov 2010 07:00

RNS Number : 3048W
Morgan Crucible Co PLC
17 November 2010
Β 

ο»Ώ

Press Release

Interim Management Statement

The Morgan Crucible Company plc

17th November 2010

Β 

Β 

The statement below constitutes Morgan Crucible's Interim Management Statement for the period from 4th July to 17th November 2010.

Β 

Β 

Β·; The Group has continued to see positive trading momentum over the period since it reported its half year results

Β 

Β·; Profits for the full year are now expected to be in the top half of analyst forecasts*

Β 

Β·; In the ten month period to October year-on-year revenue growth was c.7%. Excluding NP Aerospace and at constant currency, revenue growth over the same period was c.16%, compared to the c.10% reported at the half year

Β 

Β·; Good progress is being made to realise the benefits of the divisional streamlining that was announced at the interim results. Our expectation remains to deliver at least Β£5m of cost savings in 2011 rising to Β£6-8m in 2012

Β 

Β·; The Group's net debt to EBITDA ratio is expected to be comfortably below 2 times at the year end, driven by good cash generation from the positive trading performance

Β 

Β 

* Analyst forecasts for 2010 EBITA (before restructuring) are between Β£98.8m and Β£109.0m.

Β 

Β 

Β 

Outlook

Β 

With the Group continuing to see good trading momentum across most of its end markets, our outlook remains positive. In addition our ongoing focus on higher margin niche end markets, coupled with continuing benefits from cost base reductions, leaves us well placed for further progress into 2011.

Β 

Β Β 

Morgan Ceramics Division

Β 

The Technical Ceramics and Thermal Ceramics businesses were merged in July 2010 and are now run under a single integrated leadership team which is making good progress to realise both cost synergies and revenue growth opportunities.

Β 

Technical Ceramics Business

Β 

The majority of markets that Technical Ceramics serve have been showing improved demand during the year. US markets, in particular, have recovered strongly, Asian demand is growing well and Europe, though more subdued, is also showing a positive trend. Across the Technical Ceramics business, strong order intake through the year has resulted in order books building steadily from the trough levels of 2009.

Β 

Aerospace markets have recovered well from the slowdown seen in mid 2009 with our US metals business, in particular, benefitting from its alignment with this sector.

Demand for consumer electronics has been robust and the take-up of our new products in hard disk drive applications is very encouraging. The medical device market remains soft for the time being, mainly due to destocking in the supply chain, but there are some signs of recovery potential for 2011. In power generation, the continued weakness of the industrial gas turbine market held back our Certech businesses, in both the US and Europe, whilst solar, which started the year slowly, picked up in the second half.

Β 

Β 

Thermal Ceramics Business

Β 

Thermal Ceramics continued to see improving end market demand across all regions in the third quarter of the year. As a result, order books in emerging markets, particularly China and India, have continued to improve and the North America and Europe regions have also seen an increase in activity.

Β 

The chemical and petroleum sector remains robust with good demand in the Middle East and Latin America. Iron and steel demand has recovered from a very low base, as well as revenues from the automotive industry.

Β 

Β 

Morgan Engineered Materials Division

Β 

Advanced Materials &Technology Business - (formerly Carbon)

Β 

The Advanced Materials & Technology business has continued to recover across the broad range of its end markets in the third quarter of the year. Of particular note has been the strength of growth in our China business. The cost reduction initiatives started in 2009 and continuing in 2010, combined with our commitment to a low cost strategy, continue to yield benefits in our operating profit levels. We continue to pursue opportunities in the renewable energy sector with growing success in both the wind and solar energy markets.

Β 

Β 

NP Aerospace

Β 

NP Aerospace is expected to deliver 2010 revenues in line with our previously stated expectations of c.Β£120m. The business continues to pursue a number of domestic and international opportunities with existing and new customers. To support this, we have officially launched NP Aerospace in the US, opening an office in Detroit, and we are actively engaged with potential new customers on current and future US programmes.

Β 

Β 

Β Molten Metal Systems

Β 

The strong performance in the Molten Metal Systems business in the first half has continued through the third quarter and we have continued to see increased demand levels in emerging markets.

Β 

Β 

Financial position

Β 

There was no material change in the financial position of the Group during the period. The Group's net debt to EBITDA ratio is expected to be comfortably below 2 times at the year end.

Β 

Β 

For further enquiries:

Mark Robertshaw

Morgan Crucible

01753 837000

Kevin Dangerfield

Rollo Head/Clare Hunt

Finsbury

020 7251 3801

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSBIBDBIXBBGGL
Date   Source Headline
28th May 20257:00 amRNSTransaction in Own Shares
27th May 20258:35 amRNSHolding(s) in Company
27th May 20257:00 amRNSTransaction in Own Shares
23rd May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
21st May 20257:00 amRNSTransaction in Own Shares
20th May 20257:00 amRNSTransaction in Own Shares
19th May 20257:00 amRNSTransaction in Own Shares
16th May 202510:02 amRNSDirector/PDMR Shareholding
16th May 20257:00 amRNSTransaction in Own Shares
14th May 20254:53 pmRNSDirector/PDMR Shareholding
14th May 20254:52 pmRNSDirector/PDMR Shareholding
12th May 20257:00 amRNSTransaction in Own Shares
9th May 20257:00 amRNSTransaction in Own Shares
8th May 20251:16 pmRNSResult of AGM
8th May 20257:02 amRNSAGM Trading Update
8th May 20257:00 amRNSTransaction in Own Shares
7th May 20257:00 amRNSTransaction in Own Shares
6th May 20257:00 amRNSTransaction in Own Shares
2nd May 20257:00 amRNSTransaction in Own Shares
1st May 202511:19 amRNSTotal Voting Rights
1st May 20257:00 amRNSTransaction in Own Shares
30th Apr 20257:00 amRNSTransaction in Own Shares
29th Apr 20257:00 amRNSTransaction in Own Shares
28th Apr 20257:00 amRNSTransaction in Own Shares
25th Apr 20257:00 amRNSTransaction in Own Shares
24th Apr 20257:00 amRNSTransaction in Own Shares
23rd Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20257:00 amRNSTransaction in Own Shares
17th Apr 20257:00 amRNSTransaction in Own Shares
16th Apr 20257:00 amRNSTransaction in Own Shares
15th Apr 20257:00 amRNSTransaction in Own Shares
14th Apr 20257:00 amRNSTransaction in Own Shares
11th Apr 20257:00 amRNSTransaction in Own Shares
10th Apr 202511:07 amRNSDirector/PDMR Shareholding
10th Apr 20257:00 amRNSTransaction in Own Shares
9th Apr 20255:07 pmRNSDirector/PDMR Shareholding
9th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20257:00 amRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSTransaction in Own Shares
4th Apr 20257:00 amRNSTransaction in Own Shares
3rd Apr 20257:00 amRNSTransaction in Own Shares
2nd Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 20254:09 pmRNSTotal Voting Rights
1st Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20254:06 pmRNSDirector/PDMR Shareholding
27th Mar 20251:58 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.